Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
---|
07/17/2013 | CN102579668B Chinese medicinal enema for treating infantile bacillary dysentery in clinical nursing |
07/17/2013 | CN102552472B Chinese medicinal preparation for treating vaginitis and preparation method thereof |
07/17/2013 | CN102552160B Veterinary danofloxacin mesylate slow-release microsphere preparation as well as preparation method and application of veterinary danofloxacin mesylate slow-release microsphere preparation |
07/17/2013 | CN102533798B Recombinant denovirus for expressing foot-and-mouth disease virus type A empty capsid, and application thereof |
07/17/2013 | CN102532300B Interferon alpha mutant and polyethylene glycol derivative thereof |
07/17/2013 | CN102532299B Interferon alpha mutant and polyethylene glycol derivative thereof |
07/17/2013 | CN102526266B Chinese medicinal preparation for treating vaginitis and preparation method thereof |
07/17/2013 | CN102526132B Antifungal ear drops |
07/17/2013 | CN102526007B Florfenicol taste masking preparation and preparation method for same |
07/17/2013 | CN102525937B Preparation method for hypericin albumin nanometer particles |
07/17/2013 | CN102499982B Method for producing trivalent inactivated vaccine against Haemophilus parasuis infection |
07/17/2013 | CN102488893B Duck hemorrhagic oophoritis inactivated vaccine production method by using cell line and product thereof |
07/17/2013 | CN102488847B Traditional Chinese medicine composition for treating chicken infectious bursal disease as well as preparation method and application thereof |
07/17/2013 | CN102462668B Hydrochloric acid boningmycin solid preparation and preparation method thereof |
07/17/2013 | CN102416068B Cleaning and skin protection composition and preparation method |
07/17/2013 | CN102391370B Antimicrobial peptides, preparation method and application thereof |
07/17/2013 | CN102391365B A group of new antibiotic peptides, preparation method thereof and use thereof |
07/17/2013 | CN102391364B New antibacterial peptides as well as preparation method and application of the same |
07/17/2013 | CN102367248B Sparfloxacin hemisulphate, its preparation method and application |
07/17/2013 | CN102362895B Method for extracting medicinal ingredient against methicillin-resistant staphylococcus aureus from peony seeds |
07/17/2013 | CN102319246B Pharmaceutical combination comprising an antibacterial agent and an active substance selected from carveol, thymol, eugenol, borneol and carvacrol |
07/17/2013 | CN102274267B Preparation method of vacuum packaged pseudostellaria roots |
07/17/2013 | CN102256951B Crystalline hydrates,pharmaceutical compositions thereof and use thereof |
07/17/2013 | CN102174414B Application of new morchella costata M8-13 liquid fermentation substance in development of health-care products and medicaments |
07/17/2013 | CN102153606B Nucleoside derivatives as well as stereo isomers, pharmaceutically acceptable salts and application thereof |
07/17/2013 | CN102146142B Method for preparing astragalus polysaccharides |
07/17/2013 | CN102125687B Production method for bivalent inactivated vaccine for infectious serositis of ducks |
07/17/2013 | CN102119923B Antibiotic oil-water double suspension type injection emulsion for livestock and preparation method thereof |
07/17/2013 | CN102083434B Aqueous liquid containing gatifloxacin |
07/17/2013 | CN102056610B Fine granules having improved suspension performance in water |
07/17/2013 | CN101921330B Recombinant human interferon alpha 1b mutant and preparation method thereof |
07/17/2013 | CN101906122B Method for extracting rhoifolin and prepared medicament application thereof |
07/17/2013 | CN101879141B Taste-masking tilmicosin gastric-soluble particle preparation |
07/17/2013 | CN101878210B Amide compounds as boosters of antivirals |
07/17/2013 | CN101862444B Application of interleukin 2 in preparing preparation for resisting prawn white spot syndrome virus |
07/17/2013 | CN101784548B Purine derivatives and their use as modulators of Toll-like receptor 7 |
07/17/2013 | CN101743246B 2-oxo-2- (2-phenyl-5,6,7,8-tetrahydro-indolizin-3-yl) -acetamide derivatives and related compounds as antifungal agents |
07/17/2013 | CN101628914B Meropenem intermediate in novel crystalline form and a method of manufacture of meropenem |
07/17/2013 | CN101575361B Novel specific polypeptide and application thereof in preparing medicament for diagnosing, preventing and treating severe acute respiratory syndrome caused by coronaviruses |
07/17/2013 | CN101553489B 4-amino-3-arylamino-6-arylpyrazolo[3,4-d]pyrimidine derivatives, methods for their preparation and their use as antiviral agents |
07/17/2013 | CN101541752B 抗菌的喹啉衍生物 Antibacterial quinoline derivatives |
07/17/2013 | CN101420955B Dihydrodiazepines useful as inhibitors of protein kinases |
07/17/2013 | CN101247827B Vaccine production process |
07/17/2013 | CN101160119B Process for the preparation of poly DL-lactide-co-glycolide nanoparticles having antitubercular drugs encapsulated therein |
07/17/2013 | CN101087886B Synergistic attenuation of vesicular stomatitis virus, vectors thereof and immunogenic compositions thereof |
07/16/2013 | US8487001 Medium-chain length fatty acids, glycerides and analogues as neutrophil survival and activation factors |
07/16/2013 | US8486989 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
07/16/2013 | US8486956 Forms of rifaximin and uses thereof |
07/16/2013 | US8486464 Herbal composition for angina pectoris, method to prepare same and uses thereof |
07/16/2013 | US8486451 Adsorption and release of nitric oxide in metal organic frameworks |
07/16/2013 | US8486419 Flavivirus mutant has a deletion in the capsid protein of at least more than 4 successive amino acids, wherein the carboxy terminal hydrophobic region is not affected by the deletion |
07/16/2013 | US8486382 Method for treating cervical cancer |
07/16/2013 | CA2658884C Metal/thiol biocides |
07/16/2013 | CA2652028C Secreted campylobacter flagella coregulated proteins as immunogens |
07/16/2013 | CA2615563C Compositions and methods for controlling infections |
07/16/2013 | CA2496215C Template-fixed peptidomimetics with antibacterial activity |
07/16/2013 | CA2490542C Fas peptide mimetics and uses thereof |
07/16/2013 | CA2486106C Compounds and methods for inhibiting selectin-mediated function |
07/16/2013 | CA2485592C Anti tubercular drug: compositions and methods |
07/16/2013 | CA2464656C Spray drying methods and compositions thereof |
07/16/2013 | CA2452977C Facially amphiphilic polymers as anti-infective agents |
07/16/2013 | CA2448348C Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
07/16/2013 | CA2421935C An antimicrobial composition |
07/16/2013 | CA2358684C Antagonists of tweak and of tweak receptor and their use to treat immunological disorders |
07/12/2013 | WO2012094540A2 Methods for preparation of glycosphingolipids and uses thereof |
07/12/2013 | CA2854725A1 Methods for preparation of glycosphingolipids and uses thereof |
07/11/2013 | WO2013103969A1 Antibacterial agents: phloroglucinol derivatives |
07/11/2013 | WO2013103800A1 Anti-transferrin receptor antibodies and methods using same |
07/11/2013 | WO2013103760A1 Compositions, methods of use, and methods of treatment |
07/11/2013 | WO2013103738A1 Napthalene acetic acid derivatives against hiv infection |
07/11/2013 | WO2013103724A1 2- (tert - butoxy) -2- (7 -methylquinolin- 6 - yl) acetic acid derivatives for treating aids |
07/11/2013 | WO2013103668A1 Formulations for enhanced bioavailability of zanamivir |
07/11/2013 | WO2013103531A1 A method for treating lyme disease |
07/11/2013 | WO2013102885A1 Hygroscopic compositions for controlling relapse of herpes labialis, herpes genitalis, and herpes zoster |
07/11/2013 | WO2013102655A1 4,4-disubstituted-1,4-dihydropyrimidines and the use thereof as medicaments for the treatment of hepatitis b |
07/11/2013 | WO2013062959A3 Continuous subcutaneous administration of interferon-alpha to hepatitis b infected patients |
07/11/2013 | WO2013052958A3 Antimicrobial compositions and methods employing same |
07/11/2013 | WO2013049352A3 Anti-viral compounds |
07/11/2013 | WO2013036973A3 Methods and compositions for controlling assembly of viral proteins |
07/11/2013 | WO2012164398A3 Modulation of the ubiquitin-proteasome system (ups) |
07/11/2013 | US20130177647 Methods for manipulating satiety |
07/11/2013 | US20130177631 Method and medicament for inhibiting the expression of a given gene |
07/11/2013 | US20130177588 Multivalent Meningococcal Polysaccharide-Protein Conjugate Vaccine |
07/11/2013 | DE112011102640T5 Pharmazeutische Kombinationszusammensetzung und Verfahren zur Behandlung undPrävention von Infektionskrankheiten A pharmaceutical combination composition and methods for treating of infectious diseases undPrävention |
07/10/2013 | EP2612922A1 Eggshell membrane solubilization method using enzymes |
07/10/2013 | EP2612865A2 Crystalline peptide epoxy ketone protease inhibitors and the synthesis of amino acid keto-epoxides |
07/10/2013 | EP2612856A2 Crystalline peptide epoxy ketone protease inhibitors and the synthesis of amino acid keto-epoxides |
07/10/2013 | EP2611918A1 Mirnas involved in the blood brain barrier function |
07/10/2013 | EP2611913A2 Bacteriophage lytic enzymes as alternative antimicrobials |
07/10/2013 | EP2611823A1 Peptide containing multiple n-linked glycosylation sequons |
07/10/2013 | EP2611818A2 Phosphonate ester derivatives and methods of synthesis thereof |
07/10/2013 | EP2611806A1 Deuterium-enriched heterocyclic compounds as kinase inhibitors |
07/10/2013 | EP2611455A1 Material combination for treating inflammatory or infectious diseases |
07/10/2013 | EP2611453A1 Antifungal composition |
07/10/2013 | EP2611451A2 Design of oligonucleotide analogs as therapeutic agents |
07/10/2013 | CN103201285A Modified relaxin polypeptides and their uses |
07/10/2013 | CN103201268A Novel piperazine analogs as broad-spectrum influenza antivirals |
07/10/2013 | CN103200955A Composition comprising a peptide and an inhibitor of viral neuraminidase |
07/10/2013 | CN103200946A Compositions for treating chronic viral infections |
07/10/2013 | CN103200934A Pharmaceutical composition for treating HCV infections |